Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 333


Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma.

Yarchoan M, Agarwal P, Villanueva A, Rao S, Dawson LA, Llovet JM, Finn RS, Groopman JD, El-Serag HB, Monga SP, Wang XW, Karin M, Schwartz RE, Tanabe KK, Roberts LR, Gunaratne PH, Tsung A, Brown KA, Lawrence TS, Salem R, Singal AG, Kim AK, Rabiee A, Resar L, Hoshida Y, He AR, Ghoshal K, Ryan PB, Jaffee EM, Guha C, Mishra L, Coleman CN, Ahmed MM.

Cancer Res. 2019 Sep 1;79(17):4326-4330. doi: 10.1158/0008-5472.CAN-19-0803.


A Broad Impact for Global Oncology.

Coleman CN, Wendling EN, Pistenmaa DA.

JAMA Oncol. 2019 Aug 8. doi: 10.1001/jamaoncol.2019.2387. [Epub ahead of print] No abstract available.


Chemical, Biological, Radiological, Nuclear, and Explosive (CBRNE) Science and the CBRNE Science Medical Operations Science Support Expert (CMOSSE).

Coleman CN, Bader JL, Koerner JF, Hrdina C, Cliffer KD, Hick JL, James JJ, Mansoura MK, Livinski AA, Nystrom SV, DiCarlo-Cohen A, Marinissen MJ, Wathen L, Appler JM, Buddemeier B, Casagrande R, Estes D, Byrne P, Kennedy EM, Jakubowski AA, Case C, Weinstock DM, Dainiak N, Hanfling D, Garrett AL, Grant NN, Dodgen D, Redlener I, MacKAY TF, Treber M, Homer MJ, Taylor TP, Miller A, Korch G, Hatchett R.

Disaster Med Public Health Prep. 2019 Jun 17:1-16. doi: 10.1017/dmp.2018.163. [Epub ahead of print]


Enhancing Career Paths for Tomorrow's Radiation Oncologists.

Vapiwala N, Thomas CR Jr, Grover S, Yap ML, Mitin T, Shulman LN, Gospodarowicz MK, Longo J, Petereit DG, Ennis RD, Hayman JA, Rodin D, Buchsbaum JC, Vikram B, Abdel-Wahab M, Epstein AH, Okunieff P, Goldwein J, Kupelian P, Weidhaas JB, Tucker MA, Boice JD Jr, Fuller CD, Thompson RF, Trister AD, Formenti SC, Barcellos-Hoff MH, Jones J, Dharmarajan KV, Zietman AL, Coleman CN.

Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):52-63. doi: 10.1016/j.ijrobp.2019.05.025. Epub 2019 May 22. Review. No abstract available.


National Cancer Institute (NCI) state of the science: Targeted radiosensitizers in colorectal cancer.

George TJ, Franke AJ, Chakravarthy AB, Das P, Dasari A, El-Rayes BF, Hong TS, Kinsella TJ, Landry JC, Lee JJ, Monjazeb AM, Jacobs SA, Raben D, Rahma OE, Williams TM, Wu C, Coleman CN, Vikram B, Ahmed MM.

Cancer. 2019 Aug 15;125(16):2732-2746. doi: 10.1002/cncr.32150. Epub 2019 Apr 24. Review.


Global health and cancer.

Roth L, Wendling EC, Coleman CN, Pistenmaa DA, O'Brien DM.

Lancet. 2019 Mar 9;393(10175):983-984. doi: 10.1016/S0140-6736(19)30019-4. No abstract available.


Developing Innovative, Robust and Affordable Medical Linear Accelerators for Challenging Environments.

Dosanjh M, Aggarwal A, Pistenmaa D, Amankwaa-Frempong E, Angal-Kalinin D, Boogert S, Brown D, Carlone M, Collier P, Court L, Di Meglio A, Van Dyk J, Grover S, Jaffray DA, Jamieson C, Khader J, Konoplev I, Makwani H, McIntosh P, Militsyn B, Palta J, Sheehy S, Aruah SC, Syratchev I, Zubizarreta E, Coleman CN.

Clin Oncol (R Coll Radiol). 2019 Jun;31(6):352-355. doi: 10.1016/j.clon.2019.02.002. Epub 2019 Feb 22. No abstract available.


Decreasing the Toxicity of Radiation Therapy: Radioprotectors and Radiomitigators Being Developed by the National Cancer Institute Through Small Business Innovation Research Contracts.

Zakeri K, Narayanan D, Vikram B, Evans G, Coleman CN, Prasanna PGS.

Int J Radiat Oncol Biol Phys. 2019 May 1;104(1):188-196. doi: 10.1016/j.ijrobp.2018.12.027. Epub 2018 Dec 21. Review.


Guidance, Training and Exercises for Responding to an Improvised Nuclear Device: First Receivers, Public Health.

Case C Jr, Coleman CN, Bader JL, Hick J, Hanfling D.

Health Phys. 2018 Feb;114(2):165-172. doi: 10.1097/HP.0000000000000759.


Long-term Tumor Adaptation after Radiotherapy: Therapeutic Implications for Targeting Integrins in Prostate Cancer.

Eke I, Makinde AY, Aryankalayil MJ, Reedy JL, Citrin DE, Chopra S, Ahmed MM, Coleman CN.

Mol Cancer Res. 2018 Dec;16(12):1855-1864. doi: 10.1158/1541-7786.MCR-18-0232. Epub 2018 Jul 24.


Inhibition of Parp1 by BMN673 Effectively Sensitizes Cells to Radiotherapy by Upsetting the Balance of Repair Pathways Processing DNA Double-Strand Breaks.

Soni A, Li F, Wang Y, Grabos M, Krieger LM, Chaudhary S, Hasan MSM, Ahmed M, Coleman CN, Teicher BA, Piekarz RL, Wang D, Iliakis GE.

Mol Cancer Ther. 2018 Oct;17(10):2206-2216. doi: 10.1158/1535-7163.MCT-17-0836. Epub 2018 Jul 3.


Changing the global radiation therapy paradigm.

Pistenmaa DA, Dosanjh M, Amaldi U, Jaffray D, Zubizarreta E, Holt K, Lievens Y, Pipman Y, Coleman CN; Workshop Participants.

Radiother Oncol. 2018 Sep;128(3):393-399. doi: 10.1016/j.radonc.2018.05.025. Epub 2018 Jun 18. No abstract available.


Proposed "Exposure And Symptom Triage" (EAST) Tool to Assess Radiation Exposure After a Nuclear Detonation.

Hick JL, Bader JL, Coleman CN, Ansari AJ, Chang A, Salame-Alfie A, Hanfling D, Koerner JF.

Disaster Med Public Health Prep. 2018 Jun;12(3):386-395. doi: 10.1017/dmp.2017.86. Epub 2017 Jul 31.


Microarray analysis of miRNA expression profiles following whole body irradiation in a mouse model.

Aryankalayil MJ, Chopra S, Makinde A, Eke I, Levin J, Shankavaram U, MacMillan L, Vanpouille-Box C, Demaria S, Coleman CN.

Biomarkers. 2018 Nov;23(7):689-703. doi: 10.1080/1354750X.2018.1479771. Epub 2018 Jun 19.


Radiation Oncology in the 21st Century: Prospective Randomized Trials That Changed Practice… or Didn't!

Zakeri K, Coleman CN, Vikram B.

Front Oncol. 2018 Apr 30;8:130. doi: 10.3389/fonc.2018.00130. eCollection 2018. Review.


Accurate, Precision Radiation Medicine: A Meta-Strategy for Impacting Cancer Care, Global Health, and Nuclear Policy and Mitigating Radiation Injury From Necessary Medical Use, Space Exploration, and Potential Terrorism.

Coleman CN, Prasanna PGS, Bernhard EJ, Buchsbaum JC, Ahmed MM, Capala J, Obcemea C, Deye JA, Pistenmma DA, Vikram B, Bernier J, Dosanjh M.

Int J Radiat Oncol Biol Phys. 2018 Jun 1;101(2):250-253. doi: 10.1016/j.ijrobp.2018.02.001. No abstract available.


Workshop Report for Cancer Research: Defining the Shades of Gy: Utilizing the Biological Consequences of Radiotherapy in the Development of New Treatment Approaches-Meeting Viewpoint.

Ahmed MM, Coleman CN, Mendonca M, Bentzen S, Vikram B, Seltzer SM, Goodhead D, Obcemea C, Mohan R, Prise KM, Capala J, Citrin D, Kao G, Aryankalayil M, Eke I, Buchsbaum JC, Prasanna PGS, Liu FF, Le QT, Teicher B, Kirsch DG, Smart D, Tepper J, Formenti S, Haas-Kogan D, Raben D, Mitchell J.

Cancer Res. 2018 May 1;78(9):2166-2170. doi: 10.1158/0008-5472.CAN-17-3760. Epub 2018 Apr 23. No abstract available.


The pervasive crisis of diminishing radiation therapy access for vulnerable populations in the United States, part 2: American Indian patients.

McClelland S 3rd, Leberknight J, Guadagnolo BA, Coleman CN, Petereit DG.

Adv Radiat Oncol. 2017 Aug 26;3(1):3-7. doi: 10.1016/j.adro.2017.08.010. eCollection 2018 Jan-Mar.


Current and Future Initiatives for Radiation Oncology at the National Cancer Institute in the Era of Precision Medicine.

Kunos CA, Coleman CN.

Int J Radiat Oncol Biol Phys. 2018 Sep 1;102(1):18-25. doi: 10.1016/j.ijrobp.2017.02.225. Epub 2018 Jan 8. No abstract available.


Radiation-Induced Long Noncoding RNAs in a Mouse Model after Whole-Body Irradiation.

Aryankalayil MJ, Chopra S, Levin J, Eke I, Makinde A, Das S, Shankavaram U, Vanpouille-Box C, Demaria S, Coleman CN.

Radiat Res. 2018 Mar;189(3):251-263. doi: 10.1667/RR14891.1. Epub 2018 Jan 8.


Treatment, Not Terror: Time for Unique Problem-Solving Partnerships for Cancer Care in Resource-Challenged Environments.

Coleman CN, Pomper MA, Chao N, Dalnoki-Veress F, Pistenmaa DA.

J Glob Oncol. 2017 Dec;3(6):687-691. doi: 10.1200/JGO.2016.007591. Epub 2017 Jan 11. No abstract available.


Precision Oncology and Genomically Guided Radiation Therapy: A Report From the American Society for Radiation Oncology/American Association of Physicists in Medicine/National Cancer Institute Precision Medicine Conference.

Hall WA, Bergom C, Thompson RF, Baschnagel AM, Vijayakumar S, Willers H, Li XA, Schultz CJ, Wilson GD, West CML, Capala J, Coleman CN, Torres-Roca JF, Weidhaas J, Feng FY.

Int J Radiat Oncol Biol Phys. 2018 Jun 1;101(2):274-284. doi: 10.1016/j.ijrobp.2017.05.044. Epub 2017 Jun 9.


Exploiting Radiation-Induced Signaling to Increase the Susceptibility of Resistant Cancer Cells to Targeted Drugs: AKT and mTOR Inhibitors as an Example.

Eke I, Makinde AY, Aryankalayil MJ, Sandfort V, Palayoor ST, Rath BH, Liotta L, Pierobon M, Petricoin EF, Brown MF, Stommel JM, Ahmed MM, Coleman CN.

Mol Cancer Ther. 2018 Feb;17(2):355-367. doi: 10.1158/1535-7163.MCT-17-0262. Epub 2017 Aug 11.


The Call.

Coleman CN.

Pract Radiat Oncol. 2018 Jan - Feb;8(1):1-3. doi: 10.1016/j.prro.2017.05.006. Epub 2017 May 25. No abstract available.


DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity.

Vanpouille-Box C, Alard A, Aryankalayil MJ, Sarfraz Y, Diamond JM, Schneider RJ, Inghirami G, Coleman CN, Formenti SC, Demaria S.

Nat Commun. 2017 Jun 9;8:15618. doi: 10.1038/ncomms15618.


Radiation-agent combinations for glioblastoma: challenges in drug development and future considerations.

Kunos CA, Galanis E, Buchsbaum J, Shi Q, Strauss LC, Coleman CN, Ahmed MM.

J Neurooncol. 2017 Sep;134(3):551-557. doi: 10.1007/s11060-017-2458-0. Epub 2017 May 30. Review.


Radiation-Induced Fibrosis: Mechanisms and Opportunities to Mitigate. Report of an NCI Workshop, September 19, 2016.

Citrin DE, Prasanna PGS, Walker AJ, Freeman ML, Eke I, Barcellos-Hoff MH, Arankalayil MJ, Cohen EP, Wilkins RC, Ahmed MM, Anscher MS, Movsas B, Buchsbaum JC, Mendonca MS, Wynn TA, Coleman CN.

Radiat Res. 2017 Jul;188(1):1-20. doi: 10.1667/RR14784.1. Epub 2017 May 10.


Implementing Cancer Care for the Undeserved Globally: From the "5 R's" of Radiobiology to the "7 P's" of Global Cancer Care.

Williams TR, Coleman CN.

Semin Radiat Oncol. 2017 Apr;27(2):95-97. doi: 10.1016/j.semradonc.2016.11.012. Epub 2016 Nov 24. No abstract available.


Cancer Care Access and Outcomes for American Indian Populations in the United States: Challenges and Models for Progress.

Guadagnolo BA, Petereit DG, Coleman CN.

Semin Radiat Oncol. 2017 Apr;27(2):143-149. doi: 10.1016/j.semradonc.2016.11.006. Epub 2016 Nov 24. Review.


Global Health in Radiation Oncology: The Emergence of a New Career Pathway.

Rodin D, Yap ML, Grover S, Longo JM, Balogun O, Turner S, Eriksen JG, Coleman CN, Giuliani M.

Semin Radiat Oncol. 2017 Apr;27(2):118-123. doi: 10.1016/j.semradonc.2016.11.003. Epub 2016 Nov 9. Review.


The Radiation Stress Response: Of the People, By the People and For the People.

Coleman CN.

Radiat Res. 2017 Feb;187(2):129-146. doi: 10.1667/RR0CNC.1. Epub 2017 Jan 24.


Mobilising Expertise and Resources to Close the Radiotherapy Gap in Cancer Care.

Rodin D, Longo J, Sherertz T, Shah MM, Balagun O, Wendling N, Van Dyk J, Coleman CN, Xu MJ, Grover S.

Clin Oncol (R Coll Radiol). 2017 Feb;29(2):135-140. doi: 10.1016/j.clon.2016.11.008. Epub 2016 Dec 9.


Radiotherapy: Changing the Game in Immunotherapy.

Demaria S, Coleman CN, Formenti SC.

Trends Cancer. 2016 Jun;2(6):286-294. Review.


Comprehensive molecular tumor profiling in radiation oncology: How it could be used for precision medicine.

Eke I, Makinde AY, Aryankalayil MJ, Ahmed MM, Coleman CN.

Cancer Lett. 2016 Nov 1;382(1):118-126. doi: 10.1016/j.canlet.2016.01.041. Epub 2016 Jan 29. Review.


Masters of Our Destiny: From Jazz Quartet to Symphony Orchestra.

Coleman CN.

Int J Radiat Oncol Biol Phys. 2016 Nov 1;96(3):511-3. doi: 10.1016/j.ijrobp.2016.07.006. No abstract available.


Exploiting Gene Expression Kinetics in Conventional Radiotherapy, Hyperfractionation, and Hypofractionation for Targeted Therapy.

Makinde AY, Eke I, Aryankalayil MJ, Ahmed MM, Coleman CN.

Semin Radiat Oncol. 2016 Oct;26(4):254-60. doi: 10.1016/j.semradonc.2016.07.001. Epub 2016 Jul 5. Review.


Current Insights in Radiation Combination Therapies: Influence of Omics and Novel Targeted Agents in Defining New Concepts in Radiation Biology and Clinical Radiation Oncology.

Ahmed MM, Narendra A, Prasanna P, Coleman CN, Krishnan S.

Semin Radiat Oncol. 2016 Oct;26(4):251-3. doi: 10.1016/j.semradonc.2016.07.002. Epub 2016 Jul 5. No abstract available.


Biodosimetry: Medicine, Science, and Systems to Support the Medical Decision-Maker Following a Large Scale Nuclear or Radiation Incident.

Coleman CN, Koerner JF.

Radiat Prot Dosimetry. 2016 Dec;172(1-3):38-46. doi: 10.1093/rpd/ncw155. Epub 2016 Jul 29.


Radiotherapy for Hepatocellular Carcinoma: New Indications and Directions for Future Study.

Ohri N, Dawson LA, Krishnan S, Seong J, Cheng JC, Sarin SK, Kinkhabwala M, Ahmed MM, Vikram B, Coleman CN, Guha C.

J Natl Cancer Inst. 2016 Jul 4;108(9). pii: djw133. doi: 10.1093/jnci/djw133. Print 2016 Sep. Review.


Improving the Predictive Value of Preclinical Studies in Support of Radiotherapy Clinical Trials.

Coleman CN, Higgins GS, Brown JM, Baumann M, Kirsch DG, Willers H, Prasanna PG, Dewhirst MW, Bernhard EJ, Ahmed MM.

Clin Cancer Res. 2016 Jul 1;22(13):3138-47. doi: 10.1158/1078-0432.CCR-16-0069. Epub 2016 May 6. Review.


Preclinical Data on Efficacy of 10 Drug-Radiation Combinations: Evaluations, Concerns, and Recommendations.

Stone HB, Bernhard EJ, Coleman CN, Deye J, Capala J, Mitchell JB, Brown JM.

Transl Oncol. 2016 Feb;9(1):46-56. doi: 10.1016/j.tranon.2016.01.002. Review.


Imaging and Data Acquisition in Clinical Trials for Radiation Therapy.

FitzGerald TJ, Bishop-Jodoin M, Followill DS, Galvin J, Knopp MV, Michalski JM, Rosen MA, Bradley JD, Shankar LK, Laurie F, Cicchetti MG, Moni J, Coleman CN, Deye JA, Capala J, Vikram B.

Int J Radiat Oncol Biol Phys. 2016 Feb 1;94(2):404-11. doi: 10.1016/j.ijrobp.2015.10.028. Epub 2015 Oct 24. Review.


A Roadmap for a New Academic Pathway for Global Radiation Oncology.

Olson AC, Coleman CN, Hahn SM, DeWeese TL, Shulman LN, Chabner BA, Chao N, Martei YM, Mundt AJ, Grover S.

Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):493-6. doi: 10.1016/j.ijrobp.2015.06.023. No abstract available.


The verdict is in: the time for effective solutions to the global cancer burden is now.

Coleman CN, Minsky BD.

Lancet Oncol. 2015 Sep;16(10):1146-7. doi: 10.1016/S1470-2045(15)00276-4. No abstract available.


Radioprotectors and Radiomitigators for Improving Radiation Therapy: The Small Business Innovation Research (SBIR) Gateway for Accelerating Clinical Translation.

Prasanna PG, Narayanan D, Hallett K, Bernhard EJ, Ahmed MM, Evans G, Vikram B, Weingarten M, Coleman CN.

Radiat Res. 2015 Sep;184(3):235-48. doi: 10.1667/RR14186.1. Epub 2015 Aug 18.


Corrigendum: "Training Global Oncologists: Addressing the Global Cancer Control Problem".

Grover S, Balogun OD, Yamoah K, Groen R, Shah M, Rodin D, Martei Y, Olson AC, Slone JS, Shulman LN, Coleman CN, Hahn SM.

Front Oncol. 2015 Jun 10;5:133. doi: 10.3389/fonc.2015.00133. eCollection 2015.


Editorial: "global challenges in radiation oncology".

Petereit DG, Coleman CN.

Front Oncol. 2015 May 15;5:103. doi: 10.3389/fonc.2015.00103. eCollection 2015. No abstract available.


Training global oncologists: addressing the global cancer control problem.

Grover S, Balogun OD, Yamoah K, Groen R, Shah M, Rodin D, Olson AC, Slone JS, Shulman LN, Coleman CN, Hahn SM.

Front Oncol. 2015 Apr 8;5:80. doi: 10.3389/fonc.2015.00080. eCollection 2015. Review. No abstract available. Erratum in: Front Oncol. 2015;5:133.


Nuclear and radiological security and safety (program area committees 3 & 5)-session Q&A.

Coleman CN, Chen SY.

Health Phys. 2015 Feb;108(2):170-1. doi: 10.1097/HP.0000000000000248. No abstract available.


Supplemental Content

Loading ...
Support Center